Article Versions Notes

Pagire SH, Pagire HS, Park K-Y, Bae EJ, Kim K-e, Kim M, Yoon J, Parameswaran S, Choi J-H, Park S, et al. Identification of New Non-BBB Permeable Tryptophan Hydroxylase Inhibitors for Treating Obesity and Fatty Liver Disease. Molecules. 2022; 27(11):3417. https://doi.org/10.3390/molecules27113417

Pagire, Suvarna H., Haushabhau S. Pagire, Kun-Young Park, Eun Jung Bae, Kwang-eun Kim, Minhee Kim, Jihyeon Yoon, Saravanan Parameswaran, Jun-Ho Choi, Sungmi Park, and et al. 2022. "Identification of New Non-BBB Permeable Tryptophan Hydroxylase Inhibitors for Treating Obesity and Fatty Liver Disease" Molecules 27, no. 11: 3417. https://doi.org/10.3390/molecules27113417

Pagire, S. H., Pagire, H. S., Park, K.-Y., Bae, E. J., Kim, K.-e., Kim, M., Yoon, J., Parameswaran, S., Choi, J.-H., Park, S., Jeon, J.-H., Song, J. S., Bae, M. A., Lee, I.-K., Kim, H., Suh, J. M., & Ahn, J. H. (2022). Identification of New Non-BBB Permeable Tryptophan Hydroxylase Inhibitors for Treating Obesity and Fatty Liver Disease. Molecules, 27(11), 3417. https://doi.org/10.3390/molecules27113417